Related references
Note: Only part of the references are listed.Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study
Annick Moens et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease
Parul Tandon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab
Marco Galluzzo et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2019)
Ustekinumab exposure during conception and pregnancy in patients with chronic plaque psoriasis: a case series of 10 pregnancies
N. Watson et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
Christian Maaser et al.
JOURNAL OF CROHNS & COLITIS (2019)
Evaluation of the Developmental Toxicity of Vedolizumab, an α4β7 Receptor Antagonist, in Rabbit and Nonhuman Primate
David Crawford et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2019)
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
B. E. Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group
Uma Mahadevan et al.
GASTROENTEROLOGY (2019)
Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab
Annick Moens et al.
JOURNAL OF CROHNS & COLITIS (2019)
Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn's Disease Treated Until 33 Weeks of Gestation
Catherine R. Rowan et al.
JOURNAL OF CROHNS & COLITIS (2018)
Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease
M. Julsgaard et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature
X. Cortes et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2017)
Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series
Tamara Lund et al.
DERMATOLOGIC THERAPY (2017)
Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature
C. Venturin et al.
BMC GASTROENTEROLOGY (2017)
Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease
U. Mahadevan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn's disease and paradoxical psoriasis
E. Galli-Novak et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Outcomes Associated With Isolated Agenesis of the Corpus Callosum: A Meta-analysis
Francesco D'Antonio et al.
PEDIATRICS (2016)
The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease
C. J. van der Woude et al.
JOURNAL OF CROHNS & COLITIS (2015)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Crohn's Disease Is a Risk Factor for Preterm Birth
Olof Stephansson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Agenesis of the Corpus Callosum in California 1983-2003: A Population-Based Study
Hannah C. Glass et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
A meta-analysis on the influence of inflammatory bowel disease on pregnancy
J. Cornish et al.
GUT (2007)
A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization
N Ledee-Bataille et al.
FERTILITY AND STERILITY (2004)